Project 2 - Chang
Project 2 - Chang
批准号:
10214457
负责人:
John T Chang
金额:
$45.25万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-17 至 2023-06-30
关键词:
AcuteBody SurfaceCD8-Positive T-LymphocytesCell Differentiation processCellsCollaborationsComputer AnalysisData SetEffector CellExhibitsExposure toFURIN geneFaceFailureGene ExpressionGene Expression ProfilingGene TargetingGenerationsGenesGeneticGenetic TranscriptionGoalsGrowthHeterogeneityHost DefenseImmuneImmune responseImmunityImmunologyIndividualInfectionKnock-outLymphocyteMalignant NeoplasmsMeasurementMemoryModelingMolecularMucous MembraneNatureOutcomePopulationPrincipal InvestigatorProcessProteinsRNARNA interference screenRegulationSentinelSignal TransductionSiteSpecific qualifier valueT cell differentiationT memory cellT-LymphocyteTestingTherapeutic InterventionTimeTissuesVaccine DesignValidationWorkacute infectionbasechronic infectioncost effectivedesignexhaustexhaustionfirst respondergene discoverygenome-widein vivoinnovationinsightintestinal epitheliummicrobialnew therapeutic targetphenotypic biomarkersingle-cell RNA sequencingsmall hairpin RNAtranscriptometranscriptomics
中文摘要
摘要--项目2--常:
在对微生物感染的免疫反应中,幼稚的CD8+T淋巴细胞可以产生终末效应器
提供急性宿主防御的细胞和在功能上不同的存储单元子集,从而提供耐用
豁免权。现在认识到,一个这样的子集,组织驻留存储单元(Trm)的产生
对粘膜和身体表面的保护必不可少。精疲力竭,免疫细胞未能达到或
维持最佳功能,是发生在慢性感染和癌症背景下的另一种结果。
先前的研究已经加深了我们对CD8+T细胞如何分化为Trm或耗尽细胞的理解,
但该领域面临着该项目试图克服的几个重要挑战。我们建议采取一项
不偏不倚的、表型标记不可知的方法,利用
创新的排序方法,可实现
同一单个细胞中蛋白质和转录组的同时测量
要克服这个问题
先前的研究在群体水平上进行转录图谱分析的固有局限性。我们
将利用体内基于shRNA的方法,使我们能够反复评估50个基因的功能
同时,从而克服了传统基因敲除导致的发现速度缓慢的问题
一次评估一个基因的模型。具体地说,我们将使用这些方法来实现以下目标
目的:(1)研究Trm细胞的分子异质性和功能重要性。
(2)通过重建幼稚细胞的转录路线图来阐明trm细胞的个体发育。
通过组织内和跨组织部位的渐进性分化状态;(3)在功能上及早识别
循环和驻留在组织中的CD8+T细胞的重要分子决定因素。一大强项
我们建议的是综合和协同设计,利用单个项目的优势和
核心主要调查员,生成为多个项目提供信息的数据集。我们预见到这种洞察力
我们的研究结果可能对疫苗的合理设计和
扭转疲惫状态的治疗性干预措施。
英文摘要
SUMMARY-PROJECT 2-CHANG:
During an immune response to microbial infection, a naive CD8+ T lymphocyte can give rise to terminal effector
cells that provide acute host defense and functionally distinct subsets of memory cells that provide durable
immunity. Generation of one such subset, tissue-resident memory cells (Trm), is now recognized to be
essential for protection at mucosal and body surfaces. Exhaustion, the failure of immune cells to achieve or
maintain optimal function, is an alternative outcome that occurs in the setting of chronic infections and cancer.
Prior studies have advanced our understanding of how CD8+ T cells differentiate into Trm or exhausted cells,
but the field faces several important challenges that this Project seeks to overcome. We propose to take an
unbiased, `phenotypic marker-agnostic' approach exploiting an
innovative sequencing approach that enables
simultaneous measurement of proteins and the transcriptome in the same single cells
to overcome the
inherent limitations of prior studies that have performed transcriptional profiling at the bulk population level. We
will utilize an in vivo shRNA-based approach enabling us to reiteratively evaluate the function of 50 genes
simultaneously, thereby overcoming the slow pace of discovery resulting from traditional genetic knockout
models that evaluate one gene at a time. Specifically, we will use these approaches to achieve the following
goals: (1) Investigate the molecular heterogeneity and functional importance of Trm cells within and among
tissues; (2) Elucidate the ontogeny of Trm cells by reconstructing the transcriptomic roadmap from the naive
state through progressive states of differentiation, within and across tissue sites; (3) Identify early, functionally
important molecular determinants of exhausted circulating and tissue-resident CD8+ T cells. A major strength
of our proposal is the integrated and synergistic design that exploits the strength of the individual Project and
Core Principal Investigators, generating datasets that inform multiple Projects. We envision that insights
resulting from our studies may have important implications for the rational design of vaccines and for
therapeutic interventions that reverse the exhausted state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell subsets in inflammatory bowel disease
-
批准号:10569030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:John T Chang
-
依托单位:
T cell subsets in inflammatory bowel disease
-
批准号:10364307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:John T Chang
-
依托单位:
Transcriptional regulation of T cell immunity
-
批准号:10341041
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John T Chang
-
依托单位:
Transcriptional regulation of T cell immunity
-
批准号:10008141
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John T Chang
-
依托单位:
Transcriptional regulation of T cell immunity
-
批准号:10618783
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John T Chang
-
依托单位:
Project 2 - Chang
-
批准号:10453792
-
项目类别:
-
资助金额:$44.73万
-
财政年份:2018
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10025999
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9367846
-
项目类别:
-
资助金额:$3.02万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10308490
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10066260
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Role of proteasome activity in adaptive immunity
-
批准号:10411531
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2017
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9753899
-
项目类别:
-
资助金额:$57.0万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9980269
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Using single-cell RNA-seq to interrogate host immunity to pathogens
-
批准号:9236916
-
项目类别:
-
资助金额:$60.45万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Interrogating adaptive immunity to microbial infection
-
批准号:9138080
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:John T Chang
-
依托单位:
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
-
批准号:8448076
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Modulating the Proteasome in Inflammatory Bowel Disease
-
批准号:8436198
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
-
批准号:8302661
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Role of atypical Protein Kinase C in Inflammatory Bowel Disease
-
批准号:8637999
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
Modulating the Proteasome in Inflammatory Bowel Disease
-
批准号:8223978
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2012
-
负责人:John T Chang
-
依托单位:
海外基金